Skip to main content

Table 1 Demographic and clinical characteristics

From: Outpatient red blood cell transfusion payments among patients on chronic dialysis

 

Patients

N = 3,283a

Age, mean years (SD)

60.9 (15.0)

Sex, n male (%)

1,850 (56.4)

Geographic region, n (%)

 

  Northeast

253 (7.7)

  North Central

975 (29.7)

  South

1,459 (44.4)

  West

585 (17.8)

  Unknown

11 (0.3)

Payer, n (%)

 

  Commercial

1,941 (59.1)

  Medicare

1,342 (40.9)

Deyo Charlson comorbidity index, mean score (SD)

4.32 (2.45)

Comorbid conditions, n (%)

 

  Hypertension

3,084 (93.9)

  Diabetes

1,662 (50.6)

  CHF

1,167 (35.6)

  Acute bleeding

748 (22.8)

  Surgery

719 (21.9)

  Cancer

680 (20.7)

  COPD

460 (14.0)

  Hyperkalemia

423 (12.9)

Dialysis modality, n (%)

 

  Hemodialysis

1,997 (60.8)

  Peritoneal dialysis

207 (6.3)

  Unknown

1,095 (33.4)

Transfusion episodes with ≥ 30 days follow-up, mean number (SD)

2.15 (3.78)

Length of follow-up, mean days (SD)

494.76 (474.19)

  1. aChronic dialysis patients with ≥ 1 outpatient red blood cell transfusion episode.
  2. CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; SD, standard deviation.